• Home
  • Search Results
  • c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis.

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis.

Nature communications (2020-10-07)
Yu Chen Feng, Xiao Ying Liu, Liu Teng, Qiang Ji, Yongyan Wu, Jin Ming Li, Wei Gao, Yuan Yuan Zhang, Ting La, Hessam Tabatabaee, Xu Guang Yan, M Fairuz B Jamaluddin, Didi Zhang, Su Tang Guo, Rodney J Scott, Tao Liu, Rick F Thorne, Xu Dong Zhang, Lei Jin

The functions of the proto-oncoprotein c-Myc and the tumor suppressor p53 in controlling cell survival and proliferation are inextricably linked as "Yin and Yang" partners in normal cells to maintain tissue homeostasis: c-Myc induces the expression of ARF tumor suppressor (p14ARF in human and p19ARF in mouse) that binds to and inhibits mouse double minute 2 homolog (MDM2) leading to p53 activation, whereas p53 suppresses c-Myc through a combination of mechanisms involving transcriptional inactivation and microRNA-mediated repression. Nonetheless, the regulatory interactions between c-Myc and p53 are not retained by cancer cells as is evident from the often-imbalanced expression of c-Myc over wildtype p53. Although p53 repression in cancer cells is frequently associated with the loss of ARF, we disclose here an alternate mechanism whereby c-Myc inactivates p53 through the actions of the c-Myc-Inducible Long noncoding RNA Inactivating P53 (MILIP). MILIP functions to promote p53 polyubiquitination and turnover by reducing p53 SUMOylation through suppressing tripartite-motif family-like 2 (TRIML2). MILIP upregulation is observed amongst diverse cancer types and is shown to support cell survival, division and tumourigenicity. Thus our results uncover an inhibitory axis targeting p53 through a pan-cancer expressed RNA accomplice that links c-Myc to suppression of p53.

Product Number
Product Description

Propidium iodide, ≥94.0% (HPLC)
Doxycycline hyclate
Ginkgolic acid C15:1, analytical standard
10058-F4, ≥98% (HPLC), solid
Anti-19S regulator non-ATPase subunit S5a/Rpn10 Antibody, clone S5a-18, clone S5a-18, Upstate®, from mouse
Z-Leu-Leu-Leu-al, ≥90% (HPLC)
N-Ethylmaleimide, BioUltra, ≥99.0% (HPLC)
MG-132, Ready Made Solution, ≥90% (HPLC)